J. Horn

发表

Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury.

Charles E. Leonard, W. Bilker, C. Brensinger, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Accuracy of duplex scanning for measurement of arterial volume flow.

A. Clowes, L. Kraiss, J. Horn, 1992, Journal of vascular surgery.

Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support

Michael A. Wittie, D. Malone, A. Grizzle, 2015, Drug Safety.

ORCA: OpeRational ClassificAtion of drug interactions.

T K Hazlet, P D Hansten, P. Hansten, 2001, Journal of the American Pharmaceutical Association.

The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study

J. Horn, Stephen Ueng, 2019, The Annals of pharmacotherapy.

Clinical decision support for drug-drug interactions: improvement needed.

Shobha Phansalkar, Karl F Gumpper, John R Horn, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Therapeutic Drug Monitoring Reduces Toxic Drug Reactions: A Meta‐Analysis

L. Ried, J. Horn, D. A. McKenna, 1990, Therapeutic drug monitoring.

Proposal for a New Tool to Evaluate Drug Interaction Cases

John R Horn, P. Hansten, L. Chan, 2007, The Annals of pharmacotherapy.

Clinical Pharmacology of Proton Pump Inhibitors

J. Horn, M. Robinson, 2012, Drugs.

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy

J. Horn, L. Bauer, K. Opheim, 1986, Clinical pharmacology and therapeutics.

Effect of Metoprolol and Verapamil Administered Separately and Concurrently after Single Doses on Liver Blood Flow and Drug Disposition

D. Strandness, D. Shen, J. Horn, 2000, Journal of clinical pharmacology.

The proton-pump inhibitors: similarities and differences.

J. Horn, J. R. Horn, 2000, Clinical therapeutics.

Another thiopurine-allopurinol tragedy

P. Hansten, J. Horn, 2015 .

Coping with common GI symptoms in the community A global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort

R. Hunt, P. Whorwell, A. Emmanuel, 2013 .

Pharmacokinetics of Diclofenac Sodium in Chronic Active Hepatitis and Alcoholic Cirrhosis

D. Strandness, J. Horn, R. Carithers, 2000, Journal of clinical pharmacology.

Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.

D. Strandness, J. Horn, R. Carithers, 1994, British journal of clinical pharmacology.

Disposition of drugs in cystic fibrosis. II. Hepatic blood flow

D. Strandness, J. Horn, A. Smith, 1991, Clinical pharmacology and therapeutics.

Glipizide Pharmacokinetics: Effects of Age, Diabetes, and Multiple Dosing

J. Horn, L. Bauer, K. Opheim, 1989, Journal of clinical pharmacology.

QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data

D. Malone, P. Hansten, R. Boyce, 2022, Drugs - Real World Outcomes.

Chlorpropamide pharmacokinetics in young healthy adults and older diabetic patients.

J. Horn, L. Bauer, K. Opheim, 1987, Clinical pharmacy.

Glipizide pharmacokinetics in young and elderly volunteers.

J. Horn, L. Bauer, K. Opheim, 1988, Clinical pharmacy.

β-Blockers and Glucose Control

J. Horn, G. Mills, Gregory A. Mills, 1985, Drug intelligence & clinical pharmacy.

Drug interactions with antibacterial agents.

J. Horn, P. D. Hansten, 1995, The Journal of family practice.

Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals

Charles E. Leonard, W. Bilker, C. Brensinger, 2022, Frontiers in Pharmacology.

Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants

D. Witt, J. Horn, N. Clark, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data

D. Malone, P. Hansten, R. Boyce, 2022, Drugs - Real World Outcomes.

Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury

Charles E. Leonard, W. Bilker, C. Brensinger, 2022, Scientific Reports.

Evidence of Clinically Meaningful Drug–Drug Interaction With Concomitant Use of Colchicine and Clarithromycin

D. Malone, P. Hansten, R. Boyce, 2020, Drug Safety.

Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury.

Charles E. Leonard, W. Bilker, C. Brensinger, 2022, Journal of psychiatric research.

Estimation of Hepatic Blood Flow in Branches of Hepatic Vessels Utilizing a Noninvasive, Duplex Doppler Method

D. Strandness, J. Horn, L. Bauer, 1990, Journal of clinical pharmacology.

Acute Effects of Sublingual Nitroglycerin on Hepatic Blood Flow in Healthy Volunteers

D. Strandness, J. Horn, W. Reiss, 1994, Journal of clinical pharmacology.

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

R. Harrington, J. Horn, T. Hooton, 1999, Archives of internal medicine.

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management

D. Malone, P. Hansten, R. Boyce, 2022, Drug Safety.

Review article: similarities and differences among delayed‐release proton‐pump inhibitor formulations

J. Horn, C. Howden, C. Howden, 2005, Alimentary pharmacology & therapeutics.

Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis

D. Malone, P. Hansten, J. Horn, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions

Matthew P. Rutman, R. Stefanacci, D. Newman, 2021, Clinical Drug Investigation.

The Pharmacokinetics of Flucytosine in Cryptococcal Meningitis

J. Horn, D. Giusti, 1975 .

The Impact of Proximal Roux‐en‐Y Gastric Bypass Surgery on Acetaminophen Absorption and Metabolism

D. Flum, L. Chan, Yvonne S. Lin, 2020, Pharmacotherapy.

Stability of an extemporaneously compounded cisapride suspension.

G. Anderson, J. Horn, 1994, Clinical therapeutics.

Counseling the patient with heartburn.

J. Horn, 1991, American pharmacy.

Potentially Serious Drug Interactions Secondary to High‐Dose Diltiazem Used in the Treatment of Pulmonary Hypertension

J. Horn, I. Kawabori, W. Clarke, 1993, Pharmacotherapy.

Proximal Roux‐en‐Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P‐glycoprotein Substrates

D. Flum, L. Chan, Yvonne S. Lin, 2015, Pharmacotherapy.

Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.

J. Horn, L. Bauer, H. Pettit, 1996, Therapeutic drug monitoring.

Review article: relationship between the metabolism and efficacy of proton pump inhibitors – focus on rabeprazole

J. Horn, 2004, Alimentary pharmacology & therapeutics.

The effects of oral nifedipine on hepatic blood flow in humans

D. Strandness, J. Horn, L. Bauer, 1991, Clinical pharmacology and therapeutics.

Single and multiple doses of oral cimetidine do not change liver blood flow in humans

D. Strandness, J. Horn, L. Bauer, 1990, Clinical pharmacology and therapeutics.

Disopyramide and N-Monodesalkyl Disopyramide in Serum and Breast Milk

J. Horn, V. Raisys, A. Ellsworth, 1989, DICP : the annals of pharmacotherapy.

Lack of in vitro interaction between heparin and nitroglycerin.

J. Horn, A. Wittkowsky, A. D. Barnes, 1996, American journal of clinical pathology.

OTC polyethylene glycol 3350 and pharmacists' role in managing constipation.

J. Johanson, J. Horn, M. Mantione, 2012, Journal of the American Pharmacists Association : JAPhA.

Risk of Bleeding with Exposure to Warfarin and Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review and Meta-Analysis

D. Malone, P. Hansten, R. Boyce, 2020, Thrombosis and Haemostasis.

Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review

D. Malone, P. Hansten, R. Boyce, 2022, MedInfo.

A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)

D. Malone, R. Boyce, J. Horn, 2022, Drug Safety.

Review article: understanding the pharmacodynamic and pharmacokinetic differences between proton pump inhibitors – focus on pKa and metabolism

J. Horn, 2006 .

Propranolol-induced hallucinosis.

J. Horn, M. Rylander, H. M. Hicks, 1982, Clinical Pharmacist.

The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers

T. Gomes, D. Juurlink, M. Mamdani, 2011, Canadian Medical Association Journal.

Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

J. Horn, M. Robinson, 2003, Drugs.

Phenytoin removal by plasmapheresis in renal insufficiency.

J. Horn, L. Bauer, C. S. Brown-Molnar, 1986, American journal of nephrology.

Hansten and Horn's drug interactions analysis and managenent

John R. Horn, Philip D. Hansten, P. Hansten, 1997 .

Meta-analysis of research on the effect of clinical pharmacokinetics services on therapeutic drug monitoring.

L. Ried, J. Horn, D. A. McKenna, 1989, American journal of hospital pharmacy.

Evaluation of a Digoxin Pharmacokinetic Monitoring Service in a Community Hospital

J. Horn, D. Christensen, P. A. deBlaquiere, 1985, Drug intelligence & clinical pharmacy.

Statin–Drug Interactions: Not a Class Effect

W. Frishman, J. Horn, 2008, Cardiology in review.

Drug interactions analysis and management

John R. Horn, Philip D. Hansten, P. Hansten, 2011 .

CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis

J. Horn, M. Ritchey, Jessica C Young, 2022, Drugs - Real World Outcomes.

Population‐Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic Injury

Charles E. Leonard, W. Bilker, C. Brensinger, 2021, Clinical pharmacology and therapeutics.

A Minimal Information Model for Potential Drug-Drug Interactions

Katrina M. Romagnoli, R. Sahay, O. Beyan, 2021, Frontiers in Pharmacology.

Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire

E. Quigley, J. Horn, L. Harris, 2018, Advances in Therapy.

Potential Drug–Drug Interactions in the Outpatient Setting

Richard Platt, Marsha A Raebel, John R Horn, 2006, Medical Care.

Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

D. Malone, R. Boyce, J. Horn, 2022, Drug Safety.

Hard-stops for drug interactions.

J. Horn, 2011, Archives of internal medicine.

Coping with common gastrointestinal symptoms in the community: a global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013.

F. Guarner, R. Hunt, P. Whorwell, 2014, Journal of clinical gastroenterology.

Designing and evaluating contextualized drug–drug interaction algorithms

D. Malone, P. Hansten, R. Boyce, 2021, JAMIA open.

Performance of community pharmacy drug interaction software.

T K Hazlet, T A Lee, P D Hansten, 2001, Journal of the American Pharmaceutical Association.

Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness

Maria Liakata, Jodi Schneider, Oktie Hassanzadeh, 2013, J. Biomed. Semant..

Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics

J. Horn, L. Bauer, K. Opheim, 2004, European Journal of Clinical Pharmacology.

Toward a complete dataset of drug-drug interaction information from publicly available sources

Michel Dumontier, Mathias Brochhausen, Nicholas P. Tatonetti, 2015, J. Biomed. Informatics.

Modeling Drug Mechanism Knowledge Using Evidence and Truth Maintenance

Ira J. Kalet, Richard D. Boyce, John R. Horn, 2007, IEEE Transactions on Information Technology in Biomedicine.

Customizing clinical decision support to prevent excessive drug-drug interaction alerts.

P. Hansten, J. Horn, S. Somani, 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Influence of dietary sodium restriction on lipid metabolism

K. Schneider, J. Horn, S. Heyden, 1993, The clinical investigator.

Comment: Pitfalls in Reporting Drug Interactions

P. Hansten, J. Horn, 1993, The Annals of Pharmacotherapy.

Computing with evidence: Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment

Ira J. Kalet, Richard D. Boyce, John R. Horn, 2009, J. Biomed. Informatics.

Computing with evidence: Part II: An evidential approach to predicting metabolic drug-drug interactions

Ira J. Kalet, Richard D. Boyce, John R. Horn, 2009, J. Biomed. Informatics.

Utilizing the Wikidata System to Improve the Quality of Medical Content in Wikipedia in Diverse Languages: A Pilot Study

Alexander Pfundner, Tobias Schönberg, John Horn, 2015, Journal of medical Internet research.

Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)

D. Malone, P. Hansten, R. Boyce, 2023, The Annals of pharmacotherapy.

Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study

Charles E. Leonard, W. Bilker, C. Brensinger, 2022, CNS Drugs.

An evaluation of the potential drug interaction between warfarin and levothyroxine

D. Witt, J. Horn, N. Clark, 2014, Journal of thrombosis and haemostasis : JTH.

Comment: Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital Setting

P. Hansten, J. Horn, 2011, The Annals of pharmacotherapy.

OTC polyethylene glycol 3350 and pharmacists' role in managing constipation.

J. Johanson, J. Horn, M. Mantione, 2012, Journal of the American Pharmacists Association : JAPhA.

Statin–Drug Interactions: Not a Class Effect

W. Frishman, J. Horn, 2008, Cardiology in review.

Inhibitory Metabolic Drug Interactions with Newer Psychotropic Drugs: Inclusion in Package Inserts and Influences of Concurrence in Drug Interaction Screening Software

Richard D Boyce, Carol Collins, John Kloke, 2012, The Annals of pharmacotherapy.

Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness

Joanne S. Luciano, Maria Liakata, M. Rastegar-Mojarad, 2013, J. Biomed. Semant..

What do medical records tell us about potentially harmful co-prescribing?

L. Schultz, M. Raebel, David H. Smith, 2007, Joint Commission journal on quality and patient safety.

Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder

J. Horn, M. Ritchey, C. Girman, 2023, Drugs - Real World Outcomes.